PHG Koninklijke Philips N.V.
Healthcare$26.94-0.04%ClosedMarket Cap: $25.65B
As of 2026-05-26
Valuation
P/E (TTM)
28.93
PEG
0.13
P/B
1.99
P/S
1.28
EV/EBITDA
10.36
DCF Value
$58.52
FCF Yield
8.4%
Div Yield
3.6%
Margins & Returns
Gross Margin
45.2%
Operating Margin
9.0%
Net Margin
5.5%
ROE
9.0%
ROA
3.6%
ROIC
5.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $4.57B | 45.2% | $244.5M | $176.7M | $— | — |
| Q4 null | $5.10B | 44.9% | $540.0M | $395.0M | $— | — |
| FY null | $17.83B | 45.2% | $1.42B | $895.0M | $— | $0.89 |
| Q3 null | $4.30B | 44.4% | $330.0M | $184.0M | $— | — |
| Q2 null | $4.34B | 46.4% | $400.0M | $240.0M | $— | $0.89 |
| Q1 null | $4.10B | 45.1% | $154.0M | $76.0M | $— | — |
| Q4 null | $5.04B | 38.9% | $199.0M | $-335.0M | $— | — |
| FY null | $18.02B | 43.1% | $529.0M | $-702.0M | $— | $0.95 |
| Q3 null | $4.38B | 45.8% | $337.0M | $181.0M | $— | — |
| Q2 null | $4.46B | 44.6% | $816.0M | $451.0M | $— | $0.95 |
| Q1 null | $4.14B | 43.9% | $-824.0M | $-999.0M | $— | — |
| Q4 2023 | $5.06B | 35.5% | $24.0M | $39.0M | $0.04 | — |